Titan Pharmaceuticals Inc.

(TTNP) Trade

By |

Profile

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development of pharmaceutical products. Its product pipeline consists of Probuphine, ProNeura-Ropinirole for Parkinson's Disease, ProNeura-Triiodothyronine (T3) for hypothyroidism, Fanapt (iloperidone). It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.

Contact Information

Website: www.titanpharm.com
Email: investors@titanpharm.com
Main Phone: +1 650 244-4990
Address: 400 Oyster Point Boulevard
Address 2: Suite 505
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NSC
CEO: Sunil Bhonsle
Employees: 13
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.28 $ -0.0055 (-1.93%)
Last Price 0.28 Change $ -0.0055 Change % -1.93 Tick N/A
Bid 0.26 Bid Size 1,000.00 Ask 0.28 Ask Size 7,400.00
Open 0.29 High 0.29 Low 0.26 Prev Close 0.29
Last Trade Volume 1.5 mi 52 Wk Hi 1.55 52 Wk Low 0.17
Market Cap 21.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 77,974,644.00 EPS (TTM) -0.44 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 7
Number of Buys 0 7
Number of Sells 0 0
Net Activity 0 390000
Last 10 Buys Shares
Joseph Akers 1,000
Joseph Akers 1,000
Sunil Bhonsle 1,000
James R. Mcnab 1,000
Sunil Bhonsle 1,000
Sunil Bhonsle 1,000
James R. Mcnab 1,000
Marc Rubin 1,000
Sunil Bhonsle 1,000
Sunil Bhonsle 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8.5 8.5 8.5 8.5
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 4.95 4.95 4.95 4.95
Date of Most Recent Estimate 05/22/18 05/22/18 04/09/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3